Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:251-257
doi: 10.1161/hy0202.102702
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bukoski, R. D.
Right arrow Articles by Kunos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bukoski, R. D.
Right arrow Articles by Kunos, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Genetically altered mice
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Other Vascular biology

(Hypertension. 2002;39:251.)
© 2002 American Heart Association, Inc.


Scientific Contributions

CB1 Receptor Antagonist SR141716A Inhibits Ca2+-Induced Relaxation in CB1 Receptor-Deficient Mice

Richard D. Bukoski; Sándor Bátkai; Zoltán Járai; Yanlin Wang; Laszlo Offertaler; William F. Jackson; George Kunos

From the Cardiovascular Disease Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University (R.D.B., Y.W.), Durham; National Institute on Alcohol Abuse & Alcoholism, National Institutes of Health (S.B., Z.J., L.O., G.K.), Bethesda, Md; and Department of Biological Sciences, Western Michigan University (W.F.J.), Kalamazoo.

Correspondence to Richard Bukoski, PhD, Director, Cardiovascular Disease Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, 700 George St, Durham, NC 27707. E-mail rbukoski{at}wpo.nccu.edu

Mesenteric branch arteries isolated from cannabinoid type 1 receptor knockout (CB1-/-) mice, their wild-type littermates (CB1+/+ mice), and C57BL/J wild-type mice were studied to test the hypothesis that murine arteries undergo high sensitivity Ca2+-induced relaxation that is CB1 receptor dependent. Confocal microscope analysis of mesenteric branch arteries from wild-type mice showed the presence of Ca2+ receptor-positive periadventitial nerves. Arterial segments of C57 control mice mounted on wire myographs contracted in response to 5 µmol/L norepinephrine and responded to the cumulative addition of extracellular Ca2+ with a concentration-dependent relaxation that reached a maximum of 72.0±6.3% of the prerelaxation tone and had an EC50 for Ca2+ of 2.90±0.54 mmol/L. The relaxation was antagonized by precontraction in buffer containing 100 mmol/L K+ and by pretreatment with 10 mmol/L tetraethylammonium. Arteries from CB1-/- and CB1+/+ mice also relaxed in response to extracellular Ca2+ with no differences being detected between the knockout and their littermate controls. SR141716A, a selective CB1 antagonist, caused concentration-dependent inhibition of Ca2+-induced relaxation in both the knockout and wild-type strains (60% inhibition at 1 µmol/L). O-1918, a cannabidiol analog, had a similar blocking effect in arteries of both wild-type and CB1-/- mice at 10 µmol/L. In contrast, 1 µmol/L SR144538, a cannabinoid type 2 receptor antagonist, or 50 µmol/L 18{alpha}-glycyrrhetinic acid, a gap junction blocker, were without effect. SR141716A (1 to 30 µmol/L) was also assessed for nonspecific actions on whole-cell K+ currents in isolated vascular smooth muscle cells. SR141716A inhibited macroscopic K+ currents at concentrations higher than those required to inhibit Ca2+-induced relaxation, and appeared to have little effect on currents through large conductance Ca2+-activated K+ channels. These data indicate that arteries of the mouse relax in response to cumulative addition of extracellular Ca2+ in a hyperpolarization-dependent manner and rule out a role for CB1 or CB2 receptors in this effect. The possible role of a nonclassical cannabinoid receptor is discussed.


Key Words: mesenteric arteries • calcium • relaxation • potassium channels




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. Waldeck-Weiermair, C. Zoratti, K. Osibow, N. Balenga, E. Goessnitzer, M. Waldhoer, R. Malli, and W. F. Graier
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
J. Cell Sci., May 15, 2008; 121(10): 1704 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2363 - H2370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. M. Awumey, A. C. Howlett, J. W. Putney Jr., D. I. Diz, and R. D. Bukoski
Ca2+ mobilization through dorsal root ganglion Ca2+-sensing receptor stably expressed in HEK293 cells
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1895 - C1905.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Awumey, A. C. Howlett, and D. I. Diz
Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H520 - H521.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kofalvi, R. J. Rodrigues, C. Ledent, K. Mackie, E. S. Vizi, R. A. Cunha, and B. Sperlagh
Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis
J. Neurosci., March 16, 2005; 25(11): 2874 - 2884.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Batkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, J. Harvey-White, L. Offertaler, K. Mackie, M. A. Rudd, R. D. Bukoski, et al.
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
Circulation, October 5, 2004; 110(14): 1996 - 2002.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Koura, A. Ichihara, Y. Tada, Y. Kaneshiro, H. Okada, C. J. Temm, M. Hayashi, and T. Saruta
Anandamide Decreases Glomerular Filtration Rate through Predominant Vasodilation of Efferent Arterioles in Rat Kidneys
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1488 - 1494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Begg, F.-M. Mo, L. Offertaler, S. Batkai, P. Pacher, R. K. Razdan, D. M. Lovinger, and G. Kunos
G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current
J. Biol. Chem., November 14, 2003; 278(46): 46188 - 46194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Wang, E. K. Awumey, P. K. Chatterjee, C. Somasundaram, K. Bian, K. V. Rogers, C. Dunn, and R. D. Bukoski
Molecular cloning and characterization of a rat sensory nerve Ca2+-sensing receptor
Am J Physiol Cell Physiol, July 1, 2003; 285(1): C64 - C75.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. B. Clement, E. G. Hawkins, A. H. Lichtman, and B. F. Cravatt
Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase
J. Neurosci., May 1, 2003; 23(9): 3916 - 3923.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Offertaler, F.-M. Mo, S. Batkai, J. Liu, M. Begg, R. K. Razdan, B. R. Martin, R. D. Bukoski, and G. Kunos
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Mol. Pharmacol., March 1, 2003; 63(3): 699 - 705.
[Abstract] [Full Text] [PDF]